Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT

2.58 Up 0.03(1.18%) May 24, 4:00PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.8
Mean Recommendation (last week):1.8
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:9.75
Median Target:8.00
High Target:18.00
Low Target:5.00
No. of Brokers:4

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Sep 5, 2012Maxim GroupInitiated Buy
May 14, 2012MLV & CoInitiated Buy
Feb 16, 2012Cowen & CoInitiated Neutral
Nov 30, 2011Global Hunter SecuritiesInitiated Buy
Mar 21, 2011Dawson JamesInitiated Buy
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.